Zhejiang Jinlangbo Pharmaceutical Co., Ltd., located in Xinchang, China, is a high-tech pharmaceutical manufacturer specializing in the production of Active Pharmaceutical Ingredients (APIs), finished dosage forms, and Chinese herbal drugs. The company is a subsidiary of Jingxin Pharma and is recognized for its high-quality pharmaceutical products distributed worldwide.
Core Business and Product Offerings
Zhejiang Jinlangbo Pharmaceutical Co., Ltd. focuses on research, development, and manufacturing of APIs, finished pharmaceutical products, and traditional Chinese herbal medicines. The company adheres to stringent quality control processes and international standards to ensure product efficacy and safety.
Product Categories
-
Active Pharmaceutical Ingredients (APIs)
- Simvastatin: A lipid-lowering agent used to control hypercholesterolemia and prevent cardiovascular diseases.
- Levofloxacin Hemihydrate: A broad-spectrum antibiotic effective against various bacterial infections.
- Ciprofloxacin Hydrochloride: An antibiotic used to treat different types of bacterial infections.
- Ofloxacin: A fluoroquinolone antibiotic used in the treatment of respiratory, urinary tract, and skin infections.
- Levofloxacin Lactate: An advanced formulation of Levofloxacin used primarily in injectable solutions.
- Enrofloxacin Base: An antibacterial agent used mainly in veterinary medicine.
- Ciprofloxacin Lactate: A salt form of Ciprofloxacin offering enhanced bioavailability.
- Enrofloxacin Hydrochloride: Effective for use in veterinary applications.
- Rosuvastatin Calcium: A statin used for lowering cholesterol and reducing cardiovascular risks.
-
Finished Dosage Forms
- Simvastatin Tablets: Used for managing high cholesterol and reducing the risk of cardiovascular events.
- Gliclazide Tablets: An oral hypoglycemic agent used in the treatment of Type 2 diabetes.
- Cisapride Tablets: A prokinetic agent used for gastrointestinal motility disorders.
- Sertraline Hydrochloride Dispersing Tablets: Antidepressant used in the treatment of major depressive disorders and anxiety-related conditions.
- Cilnidipine Capsules: A calcium channel blocker used for managing hypertension.
- Lovastatin Capsules: A statin used for lowering cholesterol and preventing cardiovascular diseases.
- Fenofibrate Capsules: Used for reducing triglyceride levels and improving cholesterol profiles.
- Ciprofloxacin Hydrochloride Capsules: Broad-spectrum antibacterial capsules targeting various bacterial infections.
-
Chinese Herbal Drugs
- Coptis Bolus: A traditional herbal remedy aimed at improving digestive health.
- Mind-Easing Tonic: A herbal supplement formulated to alleviate stress and improve mental health.
- Leucorrhea Pill: Used for the treatment of gynecological conditions such as leucorrhea.
- Sexoton Pill: A natural supplement designed to enhance male health and energy levels.
- Menstruation-Regulating Bolus: A herbal remedy used to regulate menstrual cycles and improve reproductive health.
- Bolus for Indigestion: Used to treat various digestive disorders effectively.
Specialization and Unique Selling Proposition (USP)
Zhejiang Jinlangbo Pharmaceutical Co., Ltd. specializes in the production of APIs, finished dosage forms, and traditional Chinese herbal medicines. Its unique selling propositions include:
- Comprehensive Product Portfolio: A wide range of pharmaceutical products targeting various therapeutic areas including cardiovascular, metabolic, infectious, gastrointestinal, and mental health conditions.
- Research & Development: Continuous investment in R&D for developing high-quality pharmaceutical products and improving manufacturing processes.
- High Quality Standards: Adherence to international GMP standards and rigorous quality control measures ensuring product efficacy and safety.
- Integration of Traditional and Modern Medicine: Providing innovative solutions combining modern APIs with traditional Chinese herbal medicines.
- Global Market Presence: A well-established presence in domestic and international markets, particularly in Asia, Europe, and North America.
Financial Performance and Market Reach
Zhejiang Jinlangbo Pharmaceutical Co., Ltd. has established itself as a prominent player in the global pharmaceutical industry, particularly in the manufacturing of APIs and finished dosage forms. The company's revenue growth is primarily driven by its strong presence in Asia, with expanding markets in Europe and North America.
The company's high-demand products include Simvastatin, Ciprofloxacin Hydrochloride, and Rosuvastatin Calcium, which are extensively exported to pharmaceutical companies worldwide.
International Shipments Data
The company's export operations focus on markets with high demand for statins, antibiotics, and traditional Chinese herbal drugs. Major shipment destinations include:
- Asia: High demand for Simvastatin, Levofloxacin, and Ciprofloxacin-based products.
- Europe: Increasing sales of APIs such as Rosuvastatin Calcium and Simvastatin.
- North America: Exporting Ciprofloxacin Hydrochloride and other antibiotics to various pharmaceutical companies.
Certifications and Compliance Records
Zhejiang Jinlangbo Pharmaceutical Co., Ltd. adheres to stringent quality standards and has obtained certifications demonstrating its commitment to excellence, including:
- GMP Certification: Compliance with Good Manufacturing Practice ensuring high-quality pharmaceutical production.
- ISO9001: Quality Management System Certification ensuring product consistency and safety.
- FDA Approval: Several APIs meet the requirements of the United States Food and Drug Administration.
These certifications reflect the company's commitment to maintaining high standards of safety, efficacy, and quality across its entire product range.
Capabilities
The company's advanced manufacturing facilities are equipped with cutting-edge technology, enabling efficient production of APIs, finished dosage forms, and Chinese herbal drugs. Its research and development capabilities ensure continuous improvement of existing products and the development of new pharmaceutical formulations.
The company's strong supply chain management system ensures timely delivery of products to domestic and international clients, further enhancing its reputation as a reliable supplier.
Major Achievements
- Successful establishment of strategic partnerships with pharmaceutical companies worldwide.
- Continuous growth in revenue driven by strong demand for APIs and finished dosage forms.
- Development of innovative pharmaceutical formulations combining traditional Chinese medicine and modern APIs.
Customer Testimonials
Zhejiang Jinlangbo Pharmaceutical Co., Ltd. has received positive feedback from clients for its reliable supply of high-quality pharmaceutical products. Customers have praised the company's dedication to quality assurance and efficient delivery processes.
The company continues to enhance its position as a trusted supplier in the global pharmaceutical market through innovation, quality control, and customer-centric solutions aimed at meeting the evolving demands of the industry.
